Omic vs Recursion Pharmaceuticals
Multi-omics vs phenotypic imaging approaches
Omic Advantages
- ✓Digital patient simulation
- ✓PhD-level AI scientists
- ✓Free to start, paid plans from $15/month
- ✓Multi-omics integration
Recursion Strengths
- •High-throughput imaging platform
- •Proprietary cell line library
- •Phenotypic screening expertise
- •Strong pharma partnerships
Feature Comparison
| Capability | Omic | Recursion |
|---|---|---|
| Digital Patient Models | Yes | No |
| PhD-Level Autonomous Agents | Yes | No |
| High-Throughput Imaging | No | Yes |
| Multi-Omics Integration | Yes | Partial |
| Phenotypic Screening | Partial | Yes |
| Target Discovery | Yes | Yes |
| Self-Serve Pricing | Free to start, from $15/month | Enterprise only |
| Proprietary Cell Lines | No | Yes |
Try Omic Today
Experience AI-driven drug discovery free to start, with paid plans from $15/month